NORGESIC

This brand name is authorized in Austria, Finland, Hong Kong SAR China, Malta, New Zealand, Singapore.

Active ingredients

The drug NORGESIC contains a combination of these active pharmaceutical ingredients (APIs):

1	Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol
2	Orphenadrine UNII X0A40N8I4S - ORPHENADRINE CITRATE
	Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism.
	Read more about Orphenadrine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NORGESIC Tablet, uncoated	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03BC51	Orphenadrine, combinations	M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BC Ethers, chemically close to antihistamines
Discover more medicines within M03BC51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	520759, 525014
HK	Department of Health Drug Office	19321
MT	Medicines Authority	AA1507/03101
NZ	Medicines and Medical Devices Safety Authority	193
SG	Health Sciences Authority	05552P